REGARDD

The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) affiliates are comprised of regulatory affairs specialists and experts from the Southeast US that receive funding from the NIH Clinical and Translational Science Awards (CTSA) Program. Currently these institutions are the University of North Carolina at Chapel Hill, Duke University, Wake Forest School of Medicine, and RTI International, the Medical University of South Carolina, Virginia Commonwealth University, and University of Miami... ReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices... RTI international's highly experienced team can provide project management and biomedical product development expertise to plan and coordinate your preclinical and clinical projects. Our team understands drug development and regulatory approval process with..